MS-2 Step access set to expand Medical abortions will become easier to access under landmark regulation changes due to come into effect on 1 August.
GP support for changes that would help end ‘cycle of poverty’ An RACGP submission has recommended several initiatives aimed at improving access to dental care.
Confusion over UTI pharmacy prescribing ethics approval The NSW pharmacy prescribing trial is still yet to be registered with ANZCTR, despite its first phase having already begun.
More than 1000 pharmacies registered for prescribing trial The clinical trial was originally due to begin in April but issues with ethics approval reportedly resulted in it being delayed.
Wider eligibility for Paxlovid announced From 1 April the availability of the oral antiviral on the PBS will expand to include over-60s with only one risk factor for severe disease.
Breast cancer risk similar in oral contraceptives: Study While the research found similar associations between different contraceptives, the overall risk remains low, according to sexual health experts.
‘A fundamental issue’: RACGP calls for changes to reproductive healthcare At a Senate Inquiry, Dr Nicole Higgins and Professor Danielle Mazza will be pushing for greater support for GP training to build workforce capability.
Mystery over proposed pharmacy prescribing ‘trials’ NSW pharmacists will be able to side-step the TGA and extend oral contraception by July – but patient safety protections remain unclear.
Influencers spreading sexual health misinformation: Study Young people’s tendency to source contraception advice from social media, rather than doctors, has public health experts concerned.
New antiviral may offer ‘less cumbersome’ COVID treatment option The Chinese-developed oral antiviral reportedly achieves similar outcomes to Paxlovid, but with fewer side effects and drug–drug interactions.